A detailed history of Kelly Lawrence W & Associates Inc transactions in Pfizer Inc stock. As of the latest transaction made, Kelly Lawrence W & Associates Inc holds 9,130 shares of PFE stock, worth $252,901. This represents 0.06% of its overall portfolio holdings.

Number of Shares
9,130
Previous 9,130 -0.0%
Holding current value
$252,901
Previous $262,000 3.44%
% of portfolio
0.06%
Previous 0.06%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$26.13 - $33.94 $189,259 - $245,827
-7,243 Reduced 44.24%
9,130 $262,000
Q3 2023

Nov 14, 2023

SELL
$32.09 - $37.51 $30,485 - $35,634
-950 Reduced 5.48%
16,373 $543,000
Q2 2023

Aug 14, 2023

SELL
$36.12 - $41.79 $10,836 - $12,537
-300 Reduced 1.7%
17,323 $635,000
Q2 2022

Aug 15, 2022

SELL
$46.53 - $55.17 $103,529 - $122,753
-2,225 Reduced 11.21%
17,623 $924,000
Q1 2022

May 16, 2022

SELL
$45.75 - $56.69 $100,650 - $124,718
-2,200 Reduced 9.98%
19,848 $1.03 Million
Q4 2021

Feb 11, 2022

BUY
$41.32 - $61.25 $32,642 - $48,387
790 Added 3.72%
22,048 $1.3 Million
Q1 2021

May 17, 2021

BUY
$33.49 - $37.77 $504,962 - $569,496
15,078 Added 243.98%
21,258 $770,000
Q4 2020

Feb 12, 2021

SELL
$33.47 - $42.56 $516,442 - $656,700
-15,430 Reduced 71.4%
6,180 $227,000
Q2 2020

Aug 14, 2020

SELL
$30.12 - $36.54 $4,518 - $5,481
-150 Reduced 0.69%
21,610 $707,000
Q2 2019

Aug 14, 2019

BUY
$36.98 - $41.52 $29,583 - $33,216
800 Added 3.82%
21,760 $943,000
Q3 2018

Nov 14, 2018

BUY
$34.47 - $41.81 $51,705 - $62,715
1,500 Added 7.71%
20,960 $923,000
Q1 2018

May 15, 2018

SELL
$31.91 - $37.02 $40,621 - $47,126
-1,273 Reduced 6.14%
19,460 $691,000
Q4 2017

Feb 14, 2018

BUY
$33.26 - $35.29 $9,978 - $10,587
300 Added 1.47%
20,733 $751,000
Q3 2017

Nov 15, 2017

BUY
$31.0 - $34.15 $633,423 - $697,786
20,433
20,433 $729,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $155B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Kelly Lawrence W & Associates Inc Portfolio

Follow Kelly Lawrence W & Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kelly Lawrence W & Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Kelly Lawrence W & Associates Inc with notifications on news.